News About: Pharm. Industry
Flu vaccine production to be available in November
New influenza vaccine production may be available in November once the government decides to set the production amount within this month, according to Green Cross Corporation.
GCC officials said the vaccine will be...
Ilaprzole patent to be extended by 2027
Ilyang Pharm says the patent right of its ulcer drug ilaprozole will be protected by 2027 in the United States after an 8-month negotiation with TAP Pharmaceutical.
So far, TAP completed phase II trials for a novel...
Fierce battle in sibutramine market
The duel among anti-obesity drug manufactures, has reached another round on the local market.
Ilsung Pharm has recently launched its Reductil generic product, Rinovan capsule (sibutramine malreate) after changing ...
Foreign drugmakers at a crossroad
Over the years, Korean firms had to give up the home market to powerful global companies coming in with good medicine and better marketing strategies.
However, multinationals are standing on the verge of a crisis i...
Hanmi announces positive clinical data on Amozaltan
Hanmi Pharm announced positive Phase III data on its new medicine, Amozaltan (amlodipine + losartan), an oral antihypertensive agent, at the local congress hosted by the Korean Society of Nephrology and the Korean Soc...
Cash-strapped wholesalers to get financial aid
Cash-strapped drug wholesalers struggling to keep their business afloat will receive financial help from some of foreign-invested pharmaceutical firms dealing with Zuellig Pharma Korea as hospitals have delayed drug p...
Hyosung eyes pharmaceutical plant
Hyosung Group is seeking to take part in local pharmaceutical plant projects with advanced technology and recorded data the company has accumulated over the past decades.
Founded in 1957, the Hyosung Group has sinc...
LG, CMC to develop testing kits
LG Life Sciences signed a memorandum of understanding (MOU) with Catholic Medical Center (CMC) in a move to jointly develop genetic testing kits here, it was announced on May 14.
They agreed to join forces to expan...
Hanmi eyes growth through strategic alliances
Business sources say that a number of domestic pharmaceutical firms have recently established strategic alliances with multinationals for co-marketing and co-development of new drugs to effectively minimize outlays fo...
Hanall, Yungjin listed in MSCI index
Hanall Pharm and Yungjin Pharm have recently been included in the list of Morgan Stanley Capital International (MSCI) South Korea Index to gauge shares valued $100 million, according to an analyst of Daewoo Securities...
